SEC Form 4 · accession 0001689548-26-000057
Praxis Precision Medicines, Inc. · PRAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory Norden
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 5:23 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001689548
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 10, 2026 | A | 1,371 | $0.00 | A | 1,559 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $240.66 | Jun 10, 2026 | A | 648 | A | — | Jun 10, 2036 | Common Stock | 648 | 648 | D |
Explanation of responses
- F1Mr. Norden was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- F2The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.